Next-generation immunotherapies market is expected to grow significantly during the forecast period (2023-2032) owing to the increasing number of cancer cases in the 7MM, accompanied by the
The increase in the LAG 3 Next Generation Immunotherapy market size is a direct consequence of the expected entry of premium LAG-3 drugs and their readily.